- Report
- October 2023
- 181 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- January 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- January 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- February 2024
- 190 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2024
- 554 Pages
Global
From €9604EUR$9,995USD£8,211GBP
- Report
- September 2023
- 179 Pages
Global
From €3843EUR$4,000USD£3,286GBP
- Report
- March 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- August 2023
- 145 Pages
Global
From €3027EUR$3,150USD£2,588GBP
- Report
- October 2023
- 265 Pages
Global
€4415EUR$4,595USD£3,775GBP
- Report
- October 2023
- 177 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- October 2023
- 97 Pages
Global
From €2834EUR$2,950USD£2,423GBP
- Report
- June 2023
- 122 Pages
Asia Pacific
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
- Report
- October 2023
- 94 Pages
Middle East, Africa
From €2834EUR$2,950USD£2,423GBP
- Report
- October 2023
- 108 Pages
Asia Pacific
From €3315EUR$3,450USD£2,834GBP
- Report
- October 2023
- 111 Pages
Europe
From €3315EUR$3,450USD£2,834GBP
- Report
- October 2023
- 106 Pages
North America
From €2834EUR$2,950USD£2,423GBP
- Report
- October 2018
- 450 Pages
Global
From €3362EUR$3,499USD£2,874GBP
- Report
- February 2018
- 420 Pages
Global
From €3362EUR$3,499USD£2,874GBP
- Report
- March 2021
- 191 Pages
Global
From €2402EUR$2,500USD£2,054GBP
Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more